VISTAGEN THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -73.8% | -73.8% | -64.0% |
| FY2023 | -490.5% | -490.5% | -280.9% |
| FY2024 | -25.7% | -25.7% | -23.7% |
| FY2025 | -73.0% | -73.0% | -61.0% |
| FY2026 | -196.2% | -196.2% | -143.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -73.8% | -73.8% | -64.0% |
| FY2023 | -490.5% | -490.5% | -280.9% |
| FY2024 | -25.7% | -25.7% | -23.7% |
| FY2025 | -73.0% | -73.0% | -61.0% |
| FY2026 | -196.2% | -196.2% | -143.5% |